Browsing: first

Feed rapamycin to old mice and they live 9 to 14 percent longer, even when you start dosing them in the rodent equivalent of late middle age (extends lifespan). That single result, reproduced across three independent labs, is a big part of why rapamycin became the most talked-about molecule in the longevity space. So when…

The Food and Drug Administration (FDA) has approved mFlusiva®, the first mRNA-based influenza vaccine, for adults aged 50 years and older. For persons aged 65 years and older, the vaccine received accelerated approval based on immune responses; continued approval in this age group is contingent upon verification and description of clinical benefit in a confirmatory…